FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $162,000 | +7.3% | 48,776 | -1.5% | 0.00% | – |
| Q3 2019 | $151,000 | +28.0% | 49,508 | 0.0% | 0.00% | – |
| Q2 2019 | $118,000 | -36.6% | 49,508 | 0.0% | 0.00% | – |
| Q1 2019 | $186,000 | +1.6% | 49,508 | -2.9% | 0.00% | – |
| Q4 2018 | $183,000 | -31.7% | 50,999 | +9.2% | 0.00% | – |
| Q3 2018 | $268,000 | -86.0% | 46,700 | -84.1% | 0.00% | – |
| Q1 2016 | $1,908,000 | -16.4% | 293,003 | +4.2% | 0.00% | – |
| Q4 2015 | $2,281,000 | +29.4% | 281,227 | +16.9% | 0.00% | – |
| Q3 2015 | $1,763,000 | -4.0% | 240,527 | +34.3% | 0.00% | – |
| Q2 2015 | $1,836,000 | – | 179,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|